Gabapentin add‐on treatment for drug‐resistant focal epilepsy
This updated review (6 RCTs, none new) concludes gabapentin has efficacy in this setting, and seems to be fairly well‐tolerated. However further trials are needed to assess long-term effects, and to compare gabapentin with other add-on drugs.
Source:
Cochrane Database of Systematic Reviews